126 related articles for article (PubMed ID: 21121138)
1. [Pharmacogenetics in cardiovascular diseases therapy--treatment according guidelines or according the individual requirement?].
Bultas J
Cas Lek Cesk; 2010; 149(10):476-81. PubMed ID: 21121138
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular pharmacogenetics.
Myburgh R; Hochfeld WE; Dodgen TM; Ker J; Pepper MS
Pharmacol Ther; 2012 Mar; 133(3):280-90. PubMed ID: 22123178
[TBL] [Abstract][Full Text] [Related]
3. Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: impact on pharmacokinetics and clinical outcome.
Mourad M; Wallemacq P; De Meyer M; Malaise J; De Pauw L; Eddour DC; Goffin E; Lerut J; Haufroid V
Transplantation; 2008 Apr; 85(7 Suppl):S19-24. PubMed ID: 18401258
[TBL] [Abstract][Full Text] [Related]
4. [Genetic biomarkers and personalized medicine: application in cardiovascular pharmacology].
Carrillo Norte JA
Rev Enferm; 2013 Jan; 36(1):41-50. PubMed ID: 23427736
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics in cardiovascular antithrombotic therapy.
Marín F; González-Conejero R; Capranzano P; Bass TA; Roldán V; Angiolillo DJ
J Am Coll Cardiol; 2009 Sep; 54(12):1041-57. PubMed ID: 19744613
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics and personalized medicine: the future for drug prescribing.
Mitri Z; Esmerian MO; Simaan JA; Sabra R; Zgheib NK
J Med Liban; 2010; 58(2):101-4. PubMed ID: 20549897
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomics of G protein-coupled receptor ligands in cardiovascular medicine.
Rosskopf D; Michel MC
Pharmacol Rev; 2008 Dec; 60(4):513-35. PubMed ID: 19074621
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics and the concept of individualized medicine.
Shastry BS
Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics in HIV therapy.
Rodríguez-Nóvoa S; Barreiro P; Jiménez-Nacher I; Rendón A; Soriano V
AIDS Rev; 2005; 7(2):103-12. PubMed ID: 16092504
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacogenetics: pharmacokinetics and clinical implications].
Blardi P
Recenti Prog Med; 1997 Jan; 88(1):46-55. PubMed ID: 9102716
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics: from bench to byte.
Swen JJ; Wilting I; de Goede AL; Grandia L; Mulder H; Touw DJ; de Boer A; Conemans JM; Egberts TC; Klungel OH; Koopmans R; van der Weide J; Wilffert B; Guchelaar HJ; Deneer VH
Clin Pharmacol Ther; 2008 May; 83(5):781-7. PubMed ID: 18253145
[TBL] [Abstract][Full Text] [Related]
12. Enzymes and pharmacogenetics of cardiovascular drugs.
Siest G; Jeannesson E; Visvikis-Siest S
Clin Chim Acta; 2007 May; 381(1):26-31. PubMed ID: 17362901
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics in cardiovascular disorders: an update on the principal drugs.
Predazzi IM; Mango R; Norata GD; Di Daniele N; Sergi D; Romeo F; Novelli G
Am J Cardiovasc Drugs; 2013 Apr; 13(2):79-85. PubMed ID: 23539170
[TBL] [Abstract][Full Text] [Related]
14. Genetic factors in drug metabolism.
Belle DJ; Singh H
Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics for individualized cancer chemotherapy.
Efferth T; Volm M
Pharmacol Ther; 2005 Aug; 107(2):155-76. PubMed ID: 15890408
[TBL] [Abstract][Full Text] [Related]
16. Understanding the genetic causes of inter-patient variability. Clinical relevance with focus on cardiovascular drugs.
Ginghină C; Stănescu R; Coman IM; Bărbari L; Popescu BA
Rom J Intern Med; 2007; 45(4):313-9. PubMed ID: 18767405
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics in cardiovascular clinical trials.
Shah R; Darne B; Atar D; Abadie E; Adams KF; Zannad F;
Fundam Clin Pharmacol; 2004 Dec; 18(6):705-8. PubMed ID: 15548243
[TBL] [Abstract][Full Text] [Related]
18. [Companion diagnostics: significances and issues in its clinical application].
Miyachi H
Rinsho Byori; 2011 Jun; 59(6):602-9. PubMed ID: 21815484
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacokinetics: current requirements and future perspectives from a regulatory point of view.
Shah RR
Xenobiotica; 1993 Nov; 23(11):1159-93. PubMed ID: 8310705
[TBL] [Abstract][Full Text] [Related]
20. Individual response to drug therapy: bases and study approaches.
León-Cachón RB; Ascacio-Martínez JA; Barrera-Saldaña HA
Rev Invest Clin; 2012; 64(4):364-76. PubMed ID: 23227587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
